Teen eating disorders have become more rampant and severe than ever before. Hospitalizations for eating disorders doubled among adolescent girls during the pandemic, according to the Centers for Disease Control and Prevention. Although most teenagers have resumed in-person school, sports, and social activities, eating disorders, particularly anorexia, remain at an all-time high. Eating disorder-related health …
Continue reading “Eating Disorders Among Teens More Severe Than Ever”
Researchers from the University of Pittsburgh and Carnegie Mellon University have designed a neurotechnology that changes the game for people with moderate to severe stroke. This new technology stimulates the spinal cord to instantly enhance their arm and hand mobility, thereby enabling them to conduct daily activities smoothly. The tech involves a pair of thin …
With a considerable increase in Alzheimer’s cases worldwide over the years, the medical community desperately needs effective treatment now more than ever before. In September this year, pharmaceutical companies Biogen and Eisai published encouraging results from the clinical trials of a new drug called Lecanemab for Alzheimer’s patients. Lecanemab is a monoclonal antibody treatment that …
Continue reading “Lecanemab: Why a new Alzheimer’s drug has attracted praise and some concern”
Facing different challenges every day, school districts and teachers across the country are struggling to provide essential tools for students to focus and learn successfully. Connection and communication in ever evolving learning environments continue to be top of mind. Whether in the classroom, remote or hybrid learning, audio solutions such as headphones and headsets are critical in connecting students to educators, to technology and multiple forms …
January 29, 2021: The ribbon cutting ceremony offered a short respite from Advanced Technology Corp’s work schedule of continuing to roll out and innovate the COVID VADDS platform in addition to doing the same for VADDS and Vetstar. Having worked extensively with many departments within Delaware State University (DSU), it was rewarding to see them …
Two different dosing regimens demonstrated efficacy with one showing a better profile. No hospitalisations or severe cases of COVID-19 in participants treated with AZD1222. Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in preventing COVID-19, the primary endpoint, and no …
Continue reading “AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19”
The proliferation of medical technology and its ever-increasing application in the healthcare industry is seeing an unprecedented new demand. This necessitates a unified knowledge base of innovative, disruptive tech and how they are reshaping the healthcare system as we speak. InfoMed Coverage aspires to lead the change in the healthcare industry by profiling leaders and figureheads, their work in the industry, and their perspective on how they are making a difference globally.
Copyright © 2024 | InfoMed Coverage, All Rights Reserved
